磷酸化转录因子RelB蛋白抗体

英文名称    phospho-RelB(Ser551)    

中文名称    磷酸化转录因子RelB蛋白抗体    

别    名    RELB (phospho S551); RelB (phospho Ser551); RelB (Ser551); I REL; IREL; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; RelB; Reticuloendotheliosis viral oncogene homolog B; Transcription factor RelB; v rel avian reticuloendotheliosis viral oncogene homolog; v rel reticuloendotheliosis viral oncogene homolog B; RELB_HUMAN; I-Rel.    

磷酸化转录因子RelB蛋白抗体           

说 明 书    0.1ml      

产品类型    磷酸化抗体     

研究领域    肿瘤  免疫学  信号转导  转录调节因子      

抗体来源    Rabbit    

克隆类型    Polyclonal    

交叉反应    Human, Mouse, Rat, Cow, Rabbit,     

产品应用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.    

分 子 量    64kDa    

细胞定位    细胞核 细胞浆     

性    状    Lyophilized or Liquid    

浓    度    1mg/1ml    

免 疫 原    KLH conjugated Synthesised phosphopeptide derived from human RelB around the phosphorylation site of Ser551    

亚    型    IgG    

纯化方法    affinity purified by Protein A    

储 存 液    0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide    

保存条件    Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.    

磷酸化转录因子RelB蛋白抗体   产品介绍    background:
The NFKB complex consists of NFKB1 or NFKB2 bound to REL, RELA, or RELB. The NFKB complex is inhibited by I kappa B proteins (NFKBIA, or NFKBIB), which inactivate NF kappa B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I kappa B proteins by kinases (IKBKA, or IKBKB,) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF kappa B complex.

Function:
NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment.

Subunit:
Component of the NF-kappa-B RelB-p50 complex. Component of the NF-kappa-B RelB-p52 complex. Self-associates; the interaction seems to be transient and may prevent degradation allowing for heterodimer formation with p50 or p52. Interacts with NFKB1/p50, NFKB2/p52 and NFKB2/p100. Interacts with NFKBID.

Subcellular Location:
Nucleus. Cytoplasm, cytoskeleton, centrosome. Note=Co-localizes with NEK6 in the centrosome.

Post-translational modifications:
Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation.

Similarity:
Contains 1 RHD (Rel-like) domain.

Database links:
UniProtKB/Swiss-Prot: Q01201.2

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.    

磷酸化转录因子RelB蛋白抗体   

hz-0734R KGF/FGF7  纤维母细胞生长因子7抗体

hz-0735R FGF8/HBGF-8  成纤维细胞生长因子8抗体

hz-5935R KLHL7  kelch样蛋白7抗体

hz-1326R FGF10  成纤维细胞生长因子10抗体

hz-1767R FGF13  纤维母细胞生长因子13抗体

hz-5769R FGF16  成纤维细胞生长因子16抗体

hz-5770R FGF17  成纤维细胞生长因子17抗体

hz-5771R FGF19  成纤维细胞生长因子19抗体

hz-5772R FGF20  成纤维细胞生长因子20抗体

hz-1768R FGFBP  纤维细胞生长因子结合蛋白抗体

hz-5773R FGF22  成纤维细胞生长因子22抗体

hz-2318R FGF21  成纤维细胞生长因子21抗体

hz-0230R bFGFR/FGFR1  碱性成纤维细胞生长因子受体1抗体

hz-5938R DAT1/LIM domain only 3  神经细胞特异性转录因子DAT1抗体

hz-3205R Phospho-FGFR1(Tyr653/654)  磷酸化碱性成纤维细胞生长因子受体1抗体

hz-3136R Phospho-FGFR1 (Tyr766)  磷酸化碱性成纤维细胞生长因子受体1抗体

hz-5325R Phospho-FGFR1 (Tyr307)  磷酸化碱性成纤维细胞生长因子受体1抗体

hz-5326R Phospho-FGFR1+FGFR2 (Tyr463)   磷酸化碱性成纤维细胞生长因子受体1抗体

hz-5936R MOS  原癌基因丝氨酸/苏氨酸蛋白激酶MOS抗体

hz-0675R FGFR2/CD332  成纤维细胞生长因子受体2抗体

hz-1301R FGFR3/CD333  成纤维细胞生长因子受体3抗体

hz-0676R FGFR4/CD334  成纤维细胞生长因子受体4抗体

hz-5939R PBOV1  前列腺癌和乳腺癌高表达蛋白抗体

hz-6049R FGFR5/FGFRL1  成纤维细胞生长因子受体5抗体

hz-5712R FGFR1OP/FOP  成纤维细胞生长因子受体1原癌基因伴侣蛋白抗体

hz-5768R FGF23  成纤维细胞生长因子23抗体

hz-0315R FGL2  凝血酶原酶(纤维介素)抗体

hz-5940R RAD54B  DNA修复和重组蛋白RAD54B抗体

hz-0809R Fibulin 1  “衰老关键蛋白”抗体

hz-5941R RRAS2  畸胎瘤癌基因RAS相关病毒抗体

hz-0810R Fibulin 5  衰老关键蛋白抗体

hz-1240R human Fibrinogen  人纤维蛋白原抗体

hzm-1240M human Fibrinogen Monoclonal  人纤维蛋白原单克隆抗体

hz-3998R Fibrillarin  核仁纤维蛋白抗体

hz-3657R FLASH/CASP8AP2  半胱氨酸蛋白酶8相关蛋白2抗体

hz-1462R FLG  丝聚合蛋白/中间丝蛋白抗体

hz-0119R FLIP/c FLIP  凋亡调节基因之一抗体